The contract negotiation process between providers and payers is now more complex than ever, according to Baptist Health CEO Michael Mayo. In an interview, he spoke about his health system’s recent ...
Healthcare AI is developing at a rapid rate, and the industry’s attitude on how to best regulate and deploy this technology is evolving every day, according to leaders attending this year’s ViVE ...
Compounded GLP-1s have become more widespread, but are they safe? Some argue that compounding is nothing new, while others ...
In the world of Medicare Advantage, a disturbing shift is occurring. What began as a noble push toward value-based care has increasingly morphed into an aggressive pursuit of value-based payment ...
BridgeBio Pharma has received European approval for a drug that treats cardiomyopathy stemming from a rare metabolic condition, strengthening the biotech’s position to take market share from the ...
For too long, the behavioral health industry has treated accountability and transparency as burdens rather than tools for delivering better care. This lack of responsibility has harmed the 57M ...
This year's ViVE conference was full of announcements — from acquisitions to rebrands to product launches. This list compiles short summaries for seven of the conference’s most notable announcements.
Bluebird Bio, a company that steered three gene therapies to FDA approval but struggled to commercialize them, has found the cash it needs to put those therapies on stronger financial footing by ...
Hospitals excel at designing services fit for their needs. A pediatric cancer center of excellence, for example, is likely to produce superior outcomes due to its robust, experienced, cross ...
It’s not uncommon for people to have to undergo multiple rounds of In Vitro Fertilization (IVF). However, it’s an expensive procedure — the average cost of one IVF cycle is over $21,000 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results